India  
 
NewsR.in

Weight loss drug gets US nod to treat sleep apnea; India launch likely next year

IndiaTimes Tuesday, 24 December 2024
The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals. The treatment is expected to be a breakthrough by aiding weight reduction, which in turn improves breathing during sleep.
0
shares		ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Tirzepatide Tirzepatide Anti-diabetic and weight loss medication

Cost of weight-loss drug Mounjaro to be discounted in UK pharmacies when price hike comes into force, Sky News learns

 The cost of Mounjaro, one of Britain's biggest-selling weight loss drugs, will be heavily discounted across UK pharmacies when the official list price soars next..
Sky News

Maker of popular weight loss drug pauses shipments to UK

 The manufacturer of the popular weight loss drug Mounjaro has paused shipments to the UK ahead of an upcoming price hike.
Sky News

Serena Williams Reveals She's Taking Weight Loss Drug Zepbound

 Serena Williams just revealed she's taking a popular weight loss drug, Zepbound, a GLP-1 medication, admitting she first tried to do it naturally ... but nothing..
TMZ.com

You Might Like


Related videos from verified sources

Jamie Foxx Gets Stitches After Birthday Dinner Altercation, Jane Seymour Flees Malibu Home Amidst Wildfires, Jelly Roll's 120lb [Video]

Jamie Foxx Gets Stitches After Birthday Dinner Altercation, Jane Seymour Flees Malibu Home Amidst Wildfires, Jelly Roll's 120lb

Jamie Foxx receives stitches after getting hit in the mouth with a glass at his birthday dinner. The actor required stitches after an altercation that took place while celebrating his 57th birthday on..

Credit: LifeMinute.tv     Duration: 01:00Published